Pipeline Locating Articles & Analysis
4 news found
Funding to further advance Locate Bio’s regenerative medicine pipeline of orthobiologics Locate Bio, an orthobiologics focused regenerative medicine company, is pleased to announce that it has raised an oversubscribed £10 million of equity investment in a funding round co-led by existing shareholder Mercia Asset Management and new ...
Keith Valentine, Non-Executive Chair of Locate Bio, said: In January 2021, Locate Bio was granted a Breakthrough Device designation from the FDA for its investigational treatment for chronic osteomyelitis, CognitOss. ...
FDA’s Breakthrough Device Program helps accelerate patient access to more effective treatments Locate Bio, an orthobiologics focused regenerative medicine company, is pleased to announce that the U.S. ...
Optos Plc, a subsidiary of Nikon Corporation, Japan, and Amydis, Inc. today announced a clinical alliance focused on the development of an eye test by Amydis to detect Alzheimer’s disease. Amydis has developed a pipeline of compounds to detect amyloid proteins in the retina to be visualized with Optos’ market-leading optomap ultra-widefield retinal imaging devices to diagnose ...